stacey8892

"Good conversations happening at #ERIN2025 on rare bleeding disorders treatments and improved care pathways. There's real potential here!" We are happy to have Stacy, Cristina, Nathan and Dominic share their experiences facilitated by Panos.

@Hevsguttridge @QUBInterSim @QUBSONM @Oonaghmccloy Amazing initiative well done 👏🏻👏🏻👏🏻

Simulation palliative nursing care using life simulation cast models @QUBInterSim @QUBSONM A delight to be part of the team for the first palliative care sim at QUB @Oonaghmccloy

Amazing day at the beautiful Cambridge! Exhibited my MSc dissertation poster, panel talks and found myself some fellow QUB rare disease friends! @camraredisease An inspiring community of people ❤️🙌🏻

The Associate Director of Preclinical at @Healx, Emma Davis, is one of the speakers at next month's @camraredisease #RAREsummit25. Find out more about the speaker line-up so far and secure your space if you haven't already👇 ow.ly/pXmO50XcEzl

Coagulation is one of the body’s most essential defenses. For people with Glanzmann thrombasthenia, Von Willebrand disease, FVII deficiency and other bleeding disorders, a scraped knee can become an emergency, menstruation becomes life-altering, and childbirth can be tumultuous. For decades, medicine claimed addressing rare bleeding disorders was too difficult: populations too small, endpoints too complex, the path too uncertain. At Hemab, we’re redefining how medicine approaches the coagulation cascade for those left behind. See how we’re reimagining what’s possible: hemab.com

Today we announce our $157M Series C, but capital isn't the full story. The story is about bringing 21st-century treatments to people living with conditions science left behind, including Glanzmann thrombasthenia (GT), Von Willebrand disease (VWD), and Factor VII deficiency (FVIID), and the people working to change that reality. At Hemab, we’re building what should have existed decades ago: the ultimate clotting company – taking a platform-agnostic approach across the full spectrum of bleeding and clotting disorders. 👉 Swipe through to see the future we’re building together. And read about our Series C financing in full: prnewswire.com/news-releases/… The round was led by Sofinnova Partners with substantial participation from a large long-only global asset management company, and participation from additional new investors including a large global sovereign wealth fund, and Avoro Capital Advisors, alongside existing investors RA Capital Management, Novo Holdings, Access Biotechnology, Deep Track Capital, HealthCap, Invus, Avoro Ventures, Maj Invest Equity, and Rock Springs Capital.

Over the past few months I have been working with @maggiebennett2 to set up a parent and carer group within the @QUBSONM providing support and a voice for those juggling studying and caring responsibilities! We now have an amazing group of students ready to make this happen 💪

Understanding the Diagnosis, Symptoms and Treatment of Rare Bleeding Disorders - Stacey McGeown @NurseStandard hemostasistoday.com/insight/stacey… #Health #Hematology #Hemostasis #Medicine #HemostasisToday #RareBleedingDisorders #MedX #RCNiNursingStandard #MedEd

🎬 We’re BACK for #QUBAmbitionToSuccess Year 2!! The sequel that just might rival the original 👀💥 Our OG alumni kicked things off in style, and with fresh coaches + a new lineup ahead, this season’s set to inspire. Stay tuned… the best is yet to come! 🚀✨ #LoveQUB

Really important to remember #mentalhealth as we look at the physical. Carers too!

Understanding the diagnosis, symptoms and treatment of rare bleeding disorders - So happy to see this printed in the @rcni today! Raising awareness is only the beginning 🩸❤️🩸#rare #bleedingdisorders journals.rcni.com/nursing-standa…

Well done Ireland! 🙌🏻🙌🏻🙌🏻

@QUBSONM @ConnieMitc55743 may be of interest 😊

Applications now open for QUB’s PgCert in Nursing Care of Older People in Care Homes. 20 funded places available — apply now! 👉 qub.ac.uk/courses/postgr…

Former senior leaders at Lucy Letby’s hospital trust arrested nursingtimes.net/hospital-nursi…

✨ On 26-29 June, 80+ participants gathered in Brussels for our #EHCLeadership Conference! 🤝 Three days of collaboration, learning & strategic discussions. Highlights: welcoming Kazakhstan as our new member, community debates & access to care. See you in Vienna Oct 3-5! 🌟

NIPEC invite nurses and midwives to a Focus Group in July to share their experience of Preceptorship. Please register your interest at: NIPECBusiness@nipec.hscni.net We welcome your views.

Great weekend catching up with fellow NI friend @WillMcKeown 😊 in Brussels! Lots of chats about our love for stroke care, elderly care, bleeding disorders and education. Who knows what can happen 🙌🏻 @EHC_Haemophilia

Beautiful slide from Maria Elisa Mancuso summarising the molecules which can be used to treat Haemophilia at the @EHC_Haemophilia Leadership Conference.

Excited to be here in Brussels! #leadership #bleedingdisorders #rare @EHC_Haemophilia